Amniotic Products Market is Driven by Growing Incidence of Burn Injuries

Amniotic fluid is the protective liquid enclosed by the amniotic membrane that serves as a cushion for the growing fetus and facilitates the exchange of nutrients, water, and biochemical products between mother and fetus. Amniotic-derived products, comprising amniotic membrane and amniotic fluid products, are one subtype of orthobiologic that is being considered as a potential treatment option through augmentation of joint inflammation and healing. Amniotic membranes (AM) were initially employed for the treatment of skin disorders such as burns, ulcers, and wounds. The presence of a wide range of products of amniotic products used in the treatment of diseases is sustaining the need of healthcare facilities.

Purchase this report and Get a flat 50% Discount - https://www.globalinsightservices.com/checkout/single_user/GIS10237

Market Drivers

Growing incidence of burn injuries

The high incidence of the burn wound is likely to boost the growth of the market during the forecast period. According to WHO, an estimated 180,000 deaths every year are caused by burns-the high majority occur in low and middle-income economies. In India, over 1,000,000 people are moderately or severely burnt per year. Nearly 173,000 Bangladeshi children are moderately or severely burnt every year. Also, in Bangladesh, Colombia, Egypt, and Pakistan, 17% of children with burns have a temporary disability and 18% have a permanent disability.

Know More: https://www.globalinsightservices.com/reports/amniotic-products-market/

Market Opportunity

Implementation of the 21st Century Cures Act (US)

The 21st Century Cures Act was signed into law in the US in December 2016. Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation. The Act includes various provisions that may impact the development and approval of several products in the upcoming years. Under this Act, a new "Regenerative Medicine Advanced Therapy" designation has been established, along with a fast-track approval pathway for new regenerative medicine products and therapies. The implementation of this Act can potentially result in the approval of new regenerative medicine products and therapies in the US, as well as stimulate R&D activities in the field of regenerative medicine.

Request for a Sample Data and Methodology of Report - https://www.globalinsightservices.com/request-sample/GIS10237

Key  Players

The global  Amniotic Products Market report includes players like MiMedx Group, Inc. (USA), Organogenesis Inc. (USA), Integra LifeSciences (USA), Skye Biologics, Inc. (USA), Stryker Corporation (USA), Amniox Medical (USA), Katena Products, Inc. (USA), Misonix, Inc. (USA), NuCel (USA), and AlloSource (USA)

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
Email:   info@globalinsightservices.com
Phone:   +1-833-761-1700
Website:   https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, USA. We are committed to providing the highest quality data, analytics and tools to meet all of our clients' market research needs. With GIS, you can be assured of the quality of your output, robust and transparent research methodology, and excellent service.

This release was published on openPR.